308 related articles for article (PubMed ID: 29298488)
21. Structure, molecular simulation, and release of aspirin from intercalated Zn-Al-layered double hydroxides.
Meng Z; Li X; Lv F; Zhang Q; Chu PK; Zhang Y
Colloids Surf B Biointerfaces; 2015 Nov; 135():339-345. PubMed ID: 26263219
[TBL] [Abstract][Full Text] [Related]
22. Montmorillonite/poly-(ε-caprolactone) composites as versatile layered material: reservoirs for anticancer drug and controlled release property.
Kevadiya BD; Thumbar RP; Rajput MM; Rajkumar S; Brambhatt H; Joshi GV; Dangi GP; Mody HM; Gadhia PK; Bajaj HC
Eur J Pharm Sci; 2012 Aug; 47(1):265-72. PubMed ID: 22525435
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of polyurethane graft on cyclodextrin to control drug release for tumor treatment.
Shukla A; Singh AP; Ray B; Aswal V; Kar AG; Maiti P
J Colloid Interface Sci; 2019 Jan; 534():215-227. PubMed ID: 30227378
[TBL] [Abstract][Full Text] [Related]
24. Nanohybrid based on antibiotic encapsulated layered double hydroxide as a drug delivery system.
Khan SB; Alamry KA; Alyahyawi NA; Asiri AM; Arshad MN; Marwani HM
Appl Biochem Biotechnol; 2015 Feb; 175(3):1412-28. PubMed ID: 25399066
[TBL] [Abstract][Full Text] [Related]
25. A poly(ε-caprolactone) device for sustained release of an anti-glaucoma drug.
Natu MV; Gaspar MN; Ribeiro CA; Correia IJ; Silva D; de Sousa HC; Gil MH
Biomed Mater; 2011 Apr; 6(2):025003. PubMed ID: 21293056
[TBL] [Abstract][Full Text] [Related]
26. Preparation and optimization of a drug delivery system based on berberine chloride-immobilized MgAl hydrotalcite.
Djebbi MA; Bouaziz Z; Elabed A; Sadiki M; Elabed S; Namour P; Jaffrezic-Renault N; Amara AB
Int J Pharm; 2016 Jun; 506(1-2):438-48. PubMed ID: 27109050
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and characterization of a novel biocompatible pseudo-hexagonal NaCa-layered double metal hydroxides for smart pH-responsive drug release of dacarbazine and enhanced anticancer activity in malignant melanoma.
Asiabi H; Yamini Y; Alipour M; Shamsayei M; Hosseinkhani S
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():96-102. PubMed ID: 30678984
[TBL] [Abstract][Full Text] [Related]
28. In vitro controlled release of vitamin C from Ca/Al layered double hydroxide drug delivery system.
Gao X; Chen L; Xie J; Yin Y; Chang T; Duan Y; Jiang N
Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():56-60. PubMed ID: 24863197
[TBL] [Abstract][Full Text] [Related]
29. Zn-Al-NO(3)-layered double hydroxides with intercalated diclofenac for ocular delivery.
Cao F; Wang Y; Ping Q; Liao Z
Int J Pharm; 2011 Feb; 404(1-2):250-6. PubMed ID: 21093561
[TBL] [Abstract][Full Text] [Related]
30. Theranostic Bioabsorbable Bone Fixation Plate with Drug-Layered Double Hydroxide Nanohybrids.
Kim MH; Hur W; Choi G; Min HS; Choi TH; Choy YB; Choy JH
Adv Healthc Mater; 2016 Nov; 5(21):2765-2775. PubMed ID: 27723270
[TBL] [Abstract][Full Text] [Related]
31. Controlled release compound based on metanilate-layered double hydroxide nanohybrid.
Hussein MZ; Nasir NM; Yahaya AH
J Nanosci Nanotechnol; 2008 Nov; 8(11):5921-8. PubMed ID: 19198327
[TBL] [Abstract][Full Text] [Related]
32. Magnetofluorescent nanohybrid comprising polyglycerol grafted carbon dots and iron oxides: Colloidal synthesis and applications in cellular imaging and magnetically enhanced drug delivery.
Wen Y; Xu M; Liu X; Jin X; Kang J; Xu D; Sang H; Gao P; Chen X; Zhao L
Colloids Surf B Biointerfaces; 2019 Jan; 173():842-850. PubMed ID: 30551300
[TBL] [Abstract][Full Text] [Related]
33. Adsorption of nisin into layered double hydroxide nanohybrids and in-vitro controlled release.
Bouaziz Z; Djebbi MA; Soussan L; Janot JM; Amara ABH; Balme S
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():673-683. PubMed ID: 28482578
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate intercalated layered double hydroxides with different particle sizes: structural study and controlled release properties.
Zhang XQ; Zeng MG; Li SP; Li XD
Colloids Surf B Biointerfaces; 2014 May; 117():98-106. PubMed ID: 24632036
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticle-Induced Controlled Drug Delivery Using Chitosan-Based Hydrogel and Scaffold: Application to Bone Regeneration.
Mahanta AK; Senapati S; Paliwal P; Krishnamurthy S; Hemalatha S; Maiti P
Mol Pharm; 2019 Jan; 16(1):327-338. PubMed ID: 30444624
[TBL] [Abstract][Full Text] [Related]
36. Superparamagnetic Reduction/pH/Temperature Multistimuli-Responsive Nanoparticles for Targeted and Controlled Antitumor Drug Delivery.
Zeng J; Du P; Liu L; Li J; Tian K; Jia X; Zhao X; Liu P
Mol Pharm; 2015 Dec; 12(12):4188-99. PubMed ID: 26554495
[TBL] [Abstract][Full Text] [Related]
37. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells.
Kavas A; Keskin D; Altunbaş K; Tezcaner A
Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363
[TBL] [Abstract][Full Text] [Related]
38. Investigation of in vitro permeability and in vivo pharmacokinetic behavior of bare and functionalized MCM-41 and MCM-48 mesoporous silica nanoparticles: a burst and controlled drug release system for raloxifene.
Shah P; Rajput SJ
Drug Dev Ind Pharm; 2019 Apr; 45(4):587-602. PubMed ID: 30633575
[TBL] [Abstract][Full Text] [Related]
39. Anticancer drug-inorganic nanohybrid and its cellular interaction.
Kim JY; Choi SJ; Oh JM; Park T; Choy JH
J Nanosci Nanotechnol; 2007 Nov; 7(11):3700-5. PubMed ID: 18047040
[TBL] [Abstract][Full Text] [Related]
40. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
